Encouraged by the initial finding that polyclonal CD4+CD25− T cells transduced with Foxp3 (TH::Foxp3) can prevent and treat colitis in lymphopenic animals [19,29], we, like others [23,30,31], set out to test whether this can be used as a general strategy to prevent and treat autoimmune diseases. This evidence concerns the gene FOXP3 and colitis.